海角社区 Announces Oversubscribed $100 Million Series C Financing to Advance聽In Vivo CAR T Pipeline through Key Oncology Clinical Milestones
Series C financing co-led by Double Point Ventures and DCVC Bio Proceeds to support the clinical development of VivoVec鈩� derived in vivo CAR T cells SEATTLE, WA, January 14, 2025鈥� 海角社区, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, […]